Polar Capital Holdings PLC Horizon Therapeutics Public LTD CO Transaction History

Polar Capital Holdings PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $15 Million - $21.5 Million	-253,876 Reduced 15.82%	1,351,113 $83.6 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $8.89 Million - $13 Million	112,000 Added 7.5%	1,604,989 $128 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $13.1 Million - $16.6 Million	-151,252 Reduced 9.2%	1,492,989 $157 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $15.2 Million - $18.5 Million	154,359 Added 10.36%	1,644,241 $177 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $7.26 Million - $8.71 Million	78,940 Added 5.59%	1,489,882 $163 Million

Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $3.17 Million - $3.53 Million	-36,767 Reduced 2.54%	1,410,942 $132 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $28.5 Million - $37.9 Million	-397,004 Reduced 21.52%	1,447,709 $133 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $124 Million - $156 Million	1,844,713 New	1,844,713 $135 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.